A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3

NCT06273553 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Papillomavirus Associated Intraepithelial Neoplasia
Cervical Intraepithelial Neoplasia Grade 2/3
Human Papillomavirus Type 16 Infection
Human Papillomavirus Type 18 Infection

Interventions

BIOLOGICAL: RG002 injection

Sponsor

RinuaGene Biotechnology Co., Ltd.